NCT02659241 2026-04-15
Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
Clinical Trials
18 trialsNCT05080946 2026-04-01
Using Aspirin to Improve Immunological Features of Ovarian Tumors
H. Lee Moffitt Cancer Center and Research Institute
Phase EARLY_PHASE1 Recruiting
NCT03943173 2026-02-25
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT03771651 2026-02-17
Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube
University of Oklahoma
Phase EARLY_PHASE1 Active not recruiting
NCT05415709 2026-02-11
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT02111941 2025-10-31
Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT04213794 2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1 Terminated
NCT02042430 2024-12-13
Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase EARLY_PHASE1 Completed
NCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT05368506 2023-05-06
ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT05801783 2023-04-06
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer
Shanghai Yunying Medical Technology
Phase EARLY_PHASE1 Unknown
NCT02316834 2022-02-24
POSITION
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03297489 2021-10-06
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT01670799 2020-02-27
Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
New Mexico Cancer Research Alliance
Phase EARLY_PHASE1 Completed
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT01747798 2019-08-02
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02872519 2018-06-06
PET Imaging of Ovarian Carcinoma With 18F-FSPG
Vanderbilt-Ingram Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT01626014 2015-12-02
Interactive Educational Website for Women With Ovarian Cancer & Caregivers
University of Minnesota
Phase EARLY_PHASE1 Completed